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Abstract
Parkinson’s disease is the second most common neurodegenerative disease that occurs due to cellular autophagy deficiency 
and the accumulation of alpha-synuclein in the dopaminergic neurons of the substantia nigra pars compacta (SNc) of 
the brainstem. The SMER28 (also known as 6-Bromo-N-prop-2-enylquinazolin-4-amine) is an autophagy inducer. In this 
study, the neuroprotective effects of SMER28 were evaluated on autophagy induction, antioxidant system activation, and 
microgliosis attenuation. The Parkinson’s disease model was developed in the male Wistar rats by injection of 6-OHDA 
into the left striatum. Apomorphine-induced behavior assessment test and SNc cell counting were performed to investigate 
the neuroprotective effects of SMER28. This study examined the pharmacological roles of SMER28, especially by focusing 
on the autophagy (p62/ SQSTM1 and LC3II/LC3I ratio where LC3 is microtubule-associated protein 1A/1B-light chain 
3), inhibiting free radicals, and activating the antioxidant system. The levels of malondialdehyde (MDA), reactive oxygen 
species (ROS), glutathione (GSH), GSH/glutathione peroxidase  (GPX), superoxide dismutase (SOD) activity and nuclear 
factor-erythroid 2-related factor-2 (Nrf2) were measured to evaluate the antioxidant activity of SMER28. Moreover, Iba-1 
(ionized calcium binding adaptor molecule, indicating microgliosis) and tyrosine hydroxylase immunoreactivities were evalu-
ated in the SNc. In the behavioral assessment, SMER28 (50 µg/kg) attenuated damages to the SNc dopaminergic neurons, 
characterized by improved motor function. The tissue observations revealed that SMER28 prevented the destruction of SNc 
neurons and attenuated microgliosis as well. It also reduced MDA and ROS production and increased GSH,  GPX, SOD, and 
Nrf2 activities by inducing autophagy (decreasing p62 and increasing LC3II/LC3I ratio). Consequently, possibly with further 
studies, it can be considered as a drug for neurodegenerative diseases with proteinopathy etiology.
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Introduction
Parkinson’s disease is a neurodegenerative and movement 
disorder that affects 50% of people over the age of 85 years 
[1]. Even though the etiology of Parkinson’s disease is not 
completely known, a large body of evidence has shown that 
factors including oxidative stress, inflammation, mitochon-
drial damage and protein aggregations, such as alpha-synu-
clein, due to autophagy and antioxidant system dysfunction 
are involved in the destruction of substantia nigra pars com-
pacta (SNc) dopaminergic neurons.
The term ‘autophagy’, derived from the Greek meaning 
‘eating of self’. It is a self-degradative action that is essential 
for balancing energy sources at critical times in response to 
nutrient stress. It also plays a housekeeping role in clearing 
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